Find Radio Compass News for Cibinetide

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Phbsp, Ph-bsp, Ara290, Ara-290, 1208243-50-8, Ara 290
Molecular Formula
C51H84N16O21
Molecular Weight
1257.3  g/mol
InChI Key
WZTIQQBMSJTRBR-WYKNNRPVSA-N
FDA UNII
9W5677JKDA

Cibinetide
Cibinetide has been used in trials studying the basic science of Depression.
1 2D Structure

Cibinetide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4S)-5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxo-4-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid
2.1.2 InChI
InChI=1S/C51H84N16O21/c1-22(2)17-30(47(84)65-32(19-36(53)71)48(85)66-33(20-68)49(86)67-34(21-69)50(87)88)63-40(77)24(5)57-41(78)25(7-6-16-56-51(54)55)59-43(80)29(11-15-39(75)76)62-46(83)31(18-23(3)4)64-45(82)27(8-12-35(52)70)60-44(81)28(10-14-38(73)74)61-42(79)26-9-13-37(72)58-26/h22-34,68-69H,6-21H2,1-5H3,(H2,52,70)(H2,53,71)(H,57,78)(H,58,72)(H,59,80)(H,60,81)(H,61,79)(H,62,83)(H,63,77)(H,64,82)(H,65,84)(H,66,85)(H,67,86)(H,73,74)(H,75,76)(H,87,88)(H4,54,55,56)/t24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1
2.1.3 InChI Key
WZTIQQBMSJTRBR-WYKNNRPVSA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C1CCC(=O)N1
2.1.5 Isomeric SMILES
C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCC(=O)N1
2.2 Other Identifiers
2.2.1 UNII
9W5677JKDA
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ara-290

2. Ara290

3. Pglu-glu-gln-leu-glu-arg-ala-leu-asn-ser-ser

4. Phbsp Peptide

5. Pyroglutamate Helix B Surface Peptide

6. Pyroglutamate-glutamyl-glutaminyl-leucyl-glutamyl-arginyl-alanyl-leucyl-asparagyl-seryl-serine

7. Ueqleralnss

2.3.2 Depositor-Supplied Synonyms

1. Phbsp

2. Ph-bsp

3. Ara290

4. Ara-290

5. 1208243-50-8

6. Ara 290

7. Cibinetide [usan]

8. Pglu-glu-gln-leu-glu-arg-ala-leu-asn-ser-ser

9. 9w5677jkda

10. Pyr-glu-gln-leu-glu-arg-ala-leu-asn-ser-ser-oh

11. L-pyroglutamyl-l-glutamyl-l-glutaminyl-l-ieucyl-l-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-l-serine

12. L-pyroglutamyl-l-glutamyl-l-glutaminyl-l-leucyl-l-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-l-serine

13. Phbsp Peptide

14. Unii-9w5677jkda

15. Cibinetidecibinetide

16. Pyroglutamate Helix B Surface Peptide

17. Cibinetide [inn]

18. Cibinetide (usan/inn)

19. Cibinetide [who-dd]

20. Gtpl9677

21. Chembl3545305

22. Ex-a6264

23. Db13006

24. Pyroglutamate-glutamyl-glutaminyl-leucyl-glutamyl-arginyl-alanyl-leucyl-asparagyl-seryl-serine

25. L-serine, 5-oxo-l-prolyl-l-alpha-glutamyl-l-glutaminyl-l-leucyl-l-alpha-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-

26. D11218

27. Q27273306

28. L-pyr-l-glu-l-gln-l-leu-l-glu-l-arg-l-ala-l-leu-l-asn-l-ser-l-ser

29. L-serine, 5-oxo-l-prolyl-l-.alpha.-glutamyl-l-glutaminyl-l-leucyl-l-.alpha.-glutamyl-l-arginyl-l-alanyl-l-leucyl-l-asparaginyl-l-seryl-

2.4 Create Date
2015-07-11
3 Chemical and Physical Properties
Molecular Weight 1257.3 g/mol
Molecular Formula C51H84N16O21
XLogP3-7.7
Hydrogen Bond Donor Count20
Hydrogen Bond Acceptor Count22
Rotatable Bond Count42
Exact Mass1256.59969375 g/mol
Monoisotopic Mass1256.59969375 g/mol
Topological Polar Surface Area623 Ų
Heavy Atom Count88
Formal Charge0
Complexity2560
Isotope Atom Count0
Defined Atom Stereocenter Count11
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of sarcoidosis


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty